尋常性白斑 - 疫学予測 2028
Vitiligo - Epidemiology Forecast - 2028
|発行||DelveInsight Business Research LLP||商品コード||524480|
|出版日||ページ情報||英文 92 Pages
DelveInsight's 'Vitiligo - Epidemiology Forecast-2028' report deliver an in-depth understanding of the disease, historical & forecasted epidemiology of Vitiligo in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.
Study Period: 2017-2028
The American Vitiligo Research foundation defines Vitiligo as a condition in which the skin loses melanin, the pigment that determines the color of skin, hair, and eyes. If the cells that do not produce melanin die or no longer produce melanin, slowing growing white patches of irregular shapes appear on the skin. The typical lesions on the skin can be defined as milky white, non-scaly macules that are present with distinct margins. Vitiligo can also affect the mucous membranes, including tissues inside the mouth and nose. It can affect people of all skin types but is generally noticeable much in darker-skinned people.
Researchers have identified several forms of Vitiligo. Generalized Vitiligo (also called non-segmental Vitiligo), which is the most common form, involves loss of pigment (depigmentation) in patches of skin all over the body. Depigmentation typically occurs on the face, neck, and scalp, and around body openings such as the mouth and genitals. Sometimes pigment is lost in mucous membranes, such as the lips. Loss of pigmentation is also frequently seen in areas that tend to experience rubbing, impact, or other trauma, such as the hands, arms, and places where bones are close to the skin surface (bony prominences).
Another form called segmental Vitiligo (also known as unilateral or localised Vitiligo) is associated with smaller patches of depigmented skin that appear on one side of the body in a limited area; this occurs in about 10% of affected individuals. In segmental Vitiligo, the white patches only affect one area of the body. Segmental Vitiligo is less common than non-segmental Vitiligo, although it's more common in children.
The DelveInsight Vitiligo epidemiology report gives a thorough understanding of the Vitiligo by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends.
The Vitiligo epidemiology division provide insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Prevalence of Vitiligo in 7MM, Total Diagnosed Prevalence of Vitiligo in 7MM, Gender-specific Prevalence of Vitiligo in 7MM, Age-specific Diagnosed Prevalence of Vitiligo in 7MM, and Type-specific Diagnosed Prevalence of Vitiligo in 7MM) scenario of Vitiligo in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.
According to DelveInsight, the total number of prevalent population of Vitiligo was found to be 6,234,655 in 7MM in the year 2017. Also suggests the United States showed the highest number of cases with Vitiligo, as compared to other 7MM countries.
Among the European countries, Germany has the highest prevalent population with 472,057 cases followed by the United Kingdom which has prevalent population of 290,965 in 2017. DelveInsight's epidemiology model suggests that overall, female population was found to be more prevalent than male population. Based on the type of Vitiligo, non-segmental Vitiligo was found to be more prevalent, across the 7MM countries.